A 2-step synthesis of Combretastatin A-4 and derivatives as potent tubulin assembly inhibitors
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 28 (19) , 115684
Abstract
No abstract availableKeywords
Funding Information
- EPSRC (1817912)
- Kidscan - Children's Cancer Research (KGR14)
This publication has 73 references indexed in Scilit:
- Phase I Safety, Pharmacokinetic and Pharmacodynamic Evaluation of the Vascular Disrupting Agent Ombrabulin (AVE8062) in Patients with Advanced Solid TumorsClinical Cancer Research, 2013
- Synthesis and insect antifeedant activity of stilbene derivatives against Brontispa longissima LarvaeMedicinal Chemistry Research, 2012
- New Method of Synthesis and Biological Evaluation of Some Combretastatin A-4 AnaloguesSynlett, 2012
- “Artificial mitotic spindle” generated by dielectrophoresis and protein micropatterning supports bidirectional transport of kinesin-coated beadsIntegrative Biology, 2011
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate CancerCancer Research, 2010
- A Ramberg–Bäcklund route to the stilbenoid anti-cancer agents combretastatin A-4 and DMU-212Chemical Communications, 2007
- Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agentsBioorganic & Medicinal Chemistry Letters, 2007
- The Tubulin-Binding Agent Combretastatin A-4-Phosphate Arrests Endothelial Cells in Mitosis and Induces Mitotic Cell DeathThe American Journal of Pathology, 2004
- Vascular targeting effect of combretastatin A‐4 phosphate dominates the inherent angiogenesis inhibitory activityInternational Journal of Cancer, 2003
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989